News | May 28, 2026
Morepen Labs posts strong Q4 FY26 net profit
For the full year, standalone gross revenue crossed Rs. 1,700 crore
For the full year, standalone gross revenue crossed Rs. 1,700 crore
Q4FY26 revenue rises 13.6% to Rs. 14,560 crore; quarterly net profit jumps 26.2% to Rs. 2,714 crore driven by India business and Innovative Medicines growth
US formulations grew 11% to Rs. 564 crore as Alembic enters US branded pharmaceuticals market with launch of Pivya
The hospital chain reported strong growth driven by its Gurugram facility, international patient inflow, and operational efficiencies
Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance
Nine-month revenue grew 17.5% to Rs 76,277 lakh, EBITDA climbed to Rs 15,981 lakh, and net profit reached Rs 8,200 lakh
Laurus Labs has reported total income of Rs. 1,784.05 crore during the period ended December 31, 2025
Consolidated revenue from operations stood at Rs. 111.05 crore
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
Poly Medicure has reported total income of Rs. 477.82 crore during the period ended September 30, 2025
Subscribe To Our Newsletter & Stay Updated
